Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

164.92 +1.50 (+0.92%)
Official Closing Price Updated: 7:00 PM EST, Feb 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
SAN DIEGO, February 1, 2023 (Newswire.com) - On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium,... 
Via Newswire.com
3 Stocks You Can Confidently Buy in a Market Downturn
Investors can get a strong performance out of these stocks, even in a bear market. 
Via The Motley Fool
3 Warren Buffett Stocks to Buy Hand Over Fist in February
Three plain-as-day bargains are hiding in plain sight among Berkshire Hathaway's roughly four dozen holdings. 
Via The Motley Fool
Earnings Roundup: Tesla, Intel, Chevron, and More
Plus, Corrado Russo, head of global securities at Hazelview Investments, shares some insight for real estate investors. 
Via The Motley Fool
The 7 Best Climate Change Stocks to Buy for 2023
With environmental sustainability becoming an increasingly critical issue, these are the best climate change stocks to buy. 
Via InvestorPlace
Why Johnson & Johnson Stock Slipped by Nearly 4% on Monday
The fallout from the baby powder controversy continues to damage the company. 
Via The Motley Fool
Why Is Johnson & Johnson (JNJ) Stock Down Today?
Today, a rejection from a U.S. court for Johnson & Johnson to use bankruptcy to solve its ongoing Talc powder litigation has JNJ stock down. 
Via InvestorPlace
Sony Scales Back PlayStation VR2 Output, Sam Bankman-Fried Attempted To Regain Control Of FTX, White House Plans To End COVID-19 Emergency: Today's Top Stories
Bloomberg 
Via Benzinga
US Court Rejects Johnson & Johnson's Controversial Ploy To Evade Talc Cancer Lawsuits
 
Via Benzinga
Is Visa Stock a Buy?
The payments processor enjoys strong growth when the economy is stable, leading to steady stock growth as well. 
Via The Motley Fool
These 2 Stocks Led the Dow Lower Monday
Investors dealt with a pause in the January rally. 
Via The Motley Fool
J&J Dives After Court Denies Bankruptcy For Litigation-Hamstrung Baby Powder Division
Johnson & Johnson can't use bankruptcy to resolve litigation around its powders. 
Via Investor's Business Daily
2 of the Best Dividend Stocks to Own in 2023
You can count on them for passive income and growth over time. 
Via The Motley Fool
Osteotomy Plates Market Share with Top Countries Data, Size, Global Industry Challenges, Business Overview and Forecast Research Study 2028
Osteotomy Plates SWOT Analysis Including Key Players - Arthrex, Acumed, Medartis, Johnson & Johnson, Group Fh Ortho, B. Braun Melsungen, Zimmer Biomet, Stryker Corporation, aap Implantate, Wright... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. 
Via Benzinga
3 Dividend Kings to Buy Hand Over Fist in 2023
These Dividend Kings have increased dividends consecutively for 55 years or more and look hugely compelling right now. 
Via The Motley Fool
2 Blue Chips Under Pressure
Plus, Motley Fool personal finance expert Robert Brokamp answers your questions. 
Via The Motley Fool
3 Beaten-Down Blue Chip Stocks to Buy Right Now
These solid stocks are down but definitely not out. 
Via The Motley Fool
3 Low-Risk Dividend Stocks to Buy in 2023
These stocks should allow you to sleep peacefully no matter what happens with the stock market this year. 
Via The Motley Fool
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Stocks reacted well to uneven earnings and economic reports. 
Via Investor's Business Daily
The 3 Best Biotech Stocks Under $1 to Buy for January
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich. 
Via InvestorPlace
3 Warren Buffett Stocks That Could Make You Richer in 2023
These Buffett stocks are poised for a big 2023. 
Via The Motley Fool
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
A disappointing fourth-quarter performance has some investors worried about the giant healthcare conglomerate's outlook. 
Via The Motley Fool
3 Perfect Stocks for Retirees to Buy Hand Over Fist During the Nasdaq Bear Market
These highly profitable, industry-leading companies are ideal for retired investors. 
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday
Keybanc raised the price target for Reliance Steel & Aluminum Co. (NYSE: RS) from $225 to $235. Keybanc analyst Philip Gibbs maintained an Overweight rating. Reliance Steel shares fell 0.2% to close at... 
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading: 
Via Benzinga
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023
J&J's future prospects look brighter than its year-to-date stock performance might imply. 
Via The Motley Fool
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate. 
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Why Johnson & Johnson Stock Was Stagnant Today
Investors were on the fence about the company's performance in the final months of last year. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.